DK2877574T3 - Alpha (1,2)-fucosyltransferaser egnet til anvendelse i fremstillingen af fucosylerede oligosaccharider - Google Patents
Alpha (1,2)-fucosyltransferaser egnet til anvendelse i fremstillingen af fucosylerede oligosaccharider Download PDFInfo
- Publication number
- DK2877574T3 DK2877574T3 DK13823740.9T DK13823740T DK2877574T3 DK 2877574 T3 DK2877574 T3 DK 2877574T3 DK 13823740 T DK13823740 T DK 13823740T DK 2877574 T3 DK2877574 T3 DK 2877574T3
- Authority
- DK
- Denmark
- Prior art keywords
- alpha
- preparation
- fucosylated oligosaccharides
- fucosyl transferases
- transferases suitable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01069—Galactoside 2-alpha-L-fucosyltransferase (2.4.1.69)
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/60—In silico combinatorial chemistry
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Evolutionary Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Computing Systems (AREA)
- Library & Information Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/557,655 US9029136B2 (en) | 2012-07-25 | 2012-07-25 | Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides |
| PCT/US2013/051777 WO2014018596A2 (en) | 2012-07-25 | 2013-07-24 | Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2877574T3 true DK2877574T3 (da) | 2019-08-05 |
Family
ID=49995491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13823740.9T DK2877574T3 (da) | 2012-07-25 | 2013-07-24 | Alpha (1,2)-fucosyltransferaser egnet til anvendelse i fremstillingen af fucosylerede oligosaccharider |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US9029136B2 (da) |
| EP (2) | EP2877574B1 (da) |
| JP (3) | JP6355632B2 (da) |
| AU (3) | AU2013293116B2 (da) |
| CA (1) | CA2879677C (da) |
| DK (1) | DK2877574T3 (da) |
| ES (1) | ES2738589T3 (da) |
| HU (1) | HUE044693T2 (da) |
| WO (1) | WO2014018596A2 (da) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2479263B1 (en) * | 2011-01-20 | 2013-11-27 | Jennewein Biotechnologie GmbH | Novel Fucosyltransferases and their applications |
| JP6129821B2 (ja) | 2011-05-13 | 2017-05-17 | グリコシン リミテッド ライアビリティー カンパニー | プレバイオティクスとしての、精製された２’−フコシルラクトース、３−フコシルラクトース、およびラクトジフコテトラオースの使用 |
| US9029136B2 (en) | 2012-07-25 | 2015-05-12 | Glycosyn LLC | Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides |
| EP3467100B1 (en) | 2013-03-14 | 2022-09-21 | Glycosyn LLC | Microorganisms and methods for producing sialylated and n-acetylglucosamine-containing oligosaccharides |
| PL2896628T3 (pl) | 2014-01-20 | 2019-03-29 | Jennewein Biotechnologie Gmbh | Sposób wydajnego oczyszczania obojętnych oligosacharydów ludzkiego mleka (HMO) z fermentacji mikrobiologicznej |
| CA2938583A1 (en) * | 2014-02-07 | 2015-08-13 | Basf Se | Modified microorganism with improved biomass separation behaviour |
| WO2015169920A1 (en) * | 2014-05-08 | 2015-11-12 | Basf Se | Genetically modified microorganism for improved production of fine chemicals on sucrose |
| MX2016014807A (es) * | 2014-05-15 | 2017-05-10 | Glycosyn LLC | Singenes de alfa(1,2)fucosiltransferasa para su utilizacion en la produccion de oligosacaridos fucosilados. |
| US11453900B2 (en) | 2014-09-09 | 2022-09-27 | Glycosyn LLC | Alpha (1,3) fucosyltransferases for use in the production of fucosylated oligosaccharides |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| US10500221B2 (en) | 2014-12-05 | 2019-12-10 | Glycom A/S | Crystalline difucosyllactose |
| WO2016123628A1 (en) * | 2015-01-30 | 2016-08-04 | The Regents Of The University Of Colorado, A Body Corporate | Sequence specific and organism specific antimicrobials and related materials and methods |
| EP3050973A1 (en) | 2015-01-30 | 2016-08-03 | Jennewein Biotechnologie GmbH | Fermentation process for producing monosaccharides in free form from nucleotide-activated sugars |
| WO2016153300A1 (ko) * | 2015-03-24 | 2016-09-29 | 서울대학교 산학협력단 | 2-푸코실락토오스 생산 변이 미생물 및 이를 이용한 2-푸코실락토오스의 제조방법 |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| ES3011213T3 (en) | 2015-12-18 | 2025-04-07 | Glycom As | Fermentative production of oligosaccharides |
| ES2856749T3 (es) | 2016-10-29 | 2021-09-28 | Chr Hansen Hmo Gmbh | Proceso para la producción de oligosacáridos fucosilados |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| PL3375291T3 (pl) * | 2017-03-17 | 2022-11-28 | Chr. Hansen HMO GmbH | Sposób hamowania izomeryzacji sacharydu redukującego po obróbce termicznej |
| WO2018223014A1 (en) | 2017-06-02 | 2018-12-06 | Georgia State University Research Foundaton, Inc. | Dna-glycan conjugates and methods of use |
| EP3425052A1 (en) | 2017-07-07 | 2019-01-09 | Jennewein Biotechnologie GmbH | Fucosyltransferases and their use in producing fucosylated oligosaccharides |
| EP3438122A1 (en) * | 2017-08-01 | 2019-02-06 | OligoScience Biotechnology GmbH | Microorganism for producing human milk oligosaccharide |
| US11377462B2 (en) | 2017-09-29 | 2022-07-05 | Frieslandcampina Nederland B.V. | Process for the purification of a neutral human milk oligosaccharide (HMO) from microbial fermentation |
| US11274325B2 (en) | 2017-12-15 | 2022-03-15 | Glycosyn LLC | Sialyltransferases and uses thereof |
| CN109735479B (zh) * | 2019-01-30 | 2022-04-01 | 光明乳业股份有限公司 | 一种合成2’-岩藻糖基乳糖的重组枯草芽孢杆菌及其构建方法与应用 |
| EP3702468A1 (en) * | 2019-03-01 | 2020-09-02 | Jennewein Biotechnologie GmbH | Fermentative production of carbohydrates by microbial cells utilizing a mixed feedstock |
| EP3751003A1 (en) * | 2019-06-12 | 2020-12-16 | Jennewein Biotechnologie GmbH | Production of fucosylated oligosaccharides in bacillus |
| CN110846268B (zh) * | 2019-12-03 | 2021-06-25 | 齐鲁工业大学 | 一种食品级植物乳杆菌表达系统及其在酸奶制备中的应用 |
| CN114829592A (zh) * | 2019-12-17 | 2022-07-29 | 因比奥斯公司 | 转化乳糖的α-1,2-岩藻糖基转移酶 |
| CN111218488B (zh) * | 2020-02-10 | 2022-11-15 | 中国科学院上海高等研究院 | 一种利用大肠杆菌生产2’-岩藻糖基乳糖的方法 |
| CN111471606B (zh) * | 2020-03-17 | 2022-03-08 | 山东大学 | 一株优化的高产岩藻糖基乳糖的酿酒酵母菌株及其应用 |
| KR102719035B1 (ko) | 2020-04-20 | 2024-10-18 | 주식회사 리비옴 | 혈관 작동성 장 펩티드를 발현하는 미생물, 및 그의 용도 |
| US11331329B2 (en) | 2020-05-13 | 2022-05-17 | Glycosyn LLC | Fucosylated oligosaccharides for prevention of coronavirus infection |
| EP4149482A4 (en) | 2020-05-13 | 2024-05-22 | Glycosyn LLC | 2'-FUCOSYLLACTOSE FOR THE PREVENTION AND TREATMENT OF CORONAVIRUS-INDUCED INFLAMMATION |
| CN113969256A (zh) * | 2020-07-24 | 2022-01-25 | 上海交通大学 | 一种生产n-乙酰氨基葡萄糖的菌株及其构建方法和应用 |
| US12077788B2 (en) | 2020-08-10 | 2024-09-03 | Inbiose N.V. | Production of a mixture of neutral non-fucosylated oligosaccharides by a cell |
| CN112094782A (zh) * | 2020-09-27 | 2020-12-18 | 深圳市家家分类环保技术开发有限公司 | 一种用于降解厨余垃圾的复合菌剂及其制备方法 |
| CN112280795A (zh) * | 2020-11-17 | 2021-01-29 | 昆明理工大学 | 糖基转移酶基因的用途 |
| KR102793833B1 (ko) * | 2020-12-31 | 2025-04-11 | 주식회사 삼양사 | 푸코오스 전이효소를 발현하는 재조합 미생물 및 이를 이용한 2’-푸코실락토오스 제조방법 |
| KR102633804B1 (ko) * | 2020-12-31 | 2024-02-05 | 주식회사 삼양사 | 재조합 바실러스 속 미생물 및 이를 이용한 모유올리고당 제조방법 |
| JPWO2022176994A1 (da) * | 2021-02-19 | 2022-08-25 | ||
| CN112961888B (zh) * | 2021-03-03 | 2023-05-05 | 东北师范大学 | 一种重组酶在合成含有α-(1,2)糖苷键的葡聚糖中的应用 |
| CN113025548B (zh) * | 2021-04-08 | 2023-06-20 | 西南大学 | 基于kosakonia sp.菌株生产2’-岩藻糖基乳糖的重组菌及其方法和应用 |
| DK181497B1 (en) | 2021-05-17 | 2024-03-12 | Dsm Ip Assets Bv | ENHANCING FORMATION OF THE HMOS LNT AND/OR LNnT BY MODIFYING LACTOSE IMPORT IN THE CELL |
| US20240279698A1 (en) * | 2021-08-05 | 2024-08-22 | Wacker Chemie Ag | Specific alpha-1,2-fucosyltransferase for the biocatalytic synthesis of 2'-fucosyllactose |
| CN116286919A (zh) * | 2021-12-03 | 2023-06-23 | 虹摹生物科技(上海)有限公司 | 基因工程菌及利用其制备岩藻糖基化寡糖的方法 |
| EP4502168A1 (en) * | 2022-03-25 | 2025-02-05 | Kirin Holdings Kabushiki Kaisha | Production method for lactodifucotetraose (ldft) |
| EP4502160A1 (en) * | 2022-03-25 | 2025-02-05 | Kirin Holdings Kabushiki Kaisha | Protein having ?1,2-fucosyltransferase activity and method for producing lacto-n-fucopentaose i (lnfpi) |
| CN116200360B (zh) * | 2023-01-30 | 2023-09-15 | 芝诺(苏州)生物科技有限公司 | 一种futCB突变体及生物合成2’-岩藻糖基乳糖的方法 |
| WO2024253084A1 (ja) * | 2023-06-05 | 2024-12-12 | キリンホールディングス株式会社 | α１，２－フコシルトランスフェラーゼ活性を有する蛋白質及びラクト－Ｎ－フコペンタオースＩ（ＬＮＦＰＩ）の製造方法 |
| CN117467589B (zh) * | 2023-10-30 | 2024-07-26 | 江苏集萃未来食品技术研究所有限公司 | 一种高效生产3-岩藻糖基乳糖的大肠杆菌及其构建方法与应用 |
| CN120866258A (zh) * | 2024-04-29 | 2025-10-31 | 恒睿（青岛）生物科技有限公司 | 一种糖基转移酶多肽及应用 |
| CN119899815B (zh) * | 2024-12-30 | 2026-04-14 | 嘉必优生物技术（武汉）股份有限公司 | 一种α-1,2-岩藻糖基转移酶的突变体及其应用 |
| CN120505711A (zh) * | 2025-07-22 | 2025-08-19 | 三亚华大生命科学研究院 | 一种构建细菌突变体文库的方法及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6238894B1 (en) | 1998-11-04 | 2001-05-29 | Diane Taylor | α1,2 fucosyltransferase |
| US6329170B1 (en) | 1999-04-23 | 2001-12-11 | Northwest Hospital | Nucleic acids and proteins of a rat ganglioside GM1-specific α1→2fucosyltransferase and uses thereof |
| AU2001246894A1 (en) * | 2000-04-11 | 2001-10-23 | Kyowa Hakko Kogyo Co. Ltd. | Alpha1,2-fucosyltransferase and process for producing fucose-containing complex carbohydrate |
| EP1426441B1 (en) | 2001-08-24 | 2010-05-19 | Kyowa Hakko Bio Co., Ltd. | Alpha-1,2-fucosyl transferase and dna encoding the same |
| US20080145899A1 (en) | 2004-09-17 | 2008-06-19 | Neose Technologies Inc | Production of Oligosaccharides By Microorganisms |
| WO2010070104A1 (en) * | 2008-12-19 | 2010-06-24 | Jennewein Biotechnologie Gmbh | Synthesis of fucosylated compounds |
| EP2479263B1 (en) | 2011-01-20 | 2013-11-27 | Jennewein Biotechnologie GmbH | Novel Fucosyltransferases and their applications |
| EP2675899A4 (en) * | 2011-02-16 | 2014-09-10 | Glycosyn LLC | BIOSYNTHESIS OF HUMAN MILK OLIGOSACCHARIDES IN MANIPULATED BACTERIA |
| US9029136B2 (en) | 2012-07-25 | 2015-05-12 | Glycosyn LLC | Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides |
| MX2016014807A (es) * | 2014-05-15 | 2017-05-10 | Glycosyn LLC | Singenes de alfa(1,2)fucosiltransferasa para su utilizacion en la produccion de oligosacaridos fucosilados. |
-
2012
- 2012-07-25 US US13/557,655 patent/US9029136B2/en active Active
-
2013
- 2013-07-24 DK DK13823740.9T patent/DK2877574T3/da active
- 2013-07-24 CA CA2879677A patent/CA2879677C/en active Active
- 2013-07-24 EP EP13823740.9A patent/EP2877574B1/en active Active
- 2013-07-24 HU HUE13823740 patent/HUE044693T2/hu unknown
- 2013-07-24 ES ES13823740T patent/ES2738589T3/es active Active
- 2013-07-24 AU AU2013293116A patent/AU2013293116B2/en not_active Ceased
- 2013-07-24 EP EP19174435.8A patent/EP3587567A1/en not_active Withdrawn
- 2013-07-24 WO PCT/US2013/051777 patent/WO2014018596A2/en not_active Ceased
- 2013-07-24 JP JP2015524410A patent/JP6355632B2/ja not_active Expired - Fee Related
-
2015
- 2015-05-11 US US14/708,568 patent/US10273516B2/en active Active
-
2018
- 2018-02-06 JP JP2018018760A patent/JP6944886B2/ja not_active Expired - Fee Related
-
2019
- 2019-04-29 US US16/397,755 patent/US11236376B2/en not_active Expired - Fee Related
- 2019-05-15 AU AU2019203433A patent/AU2019203433C1/en not_active Ceased
- 2019-09-06 AU AU2019226246A patent/AU2019226246A1/en not_active Abandoned
-
2020
- 2020-04-03 JP JP2020067403A patent/JP2020127403A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013293116A1 (en) | 2015-02-05 |
| ES2738589T3 (es) | 2020-01-23 |
| EP3587567A1 (en) | 2020-01-01 |
| US11236376B2 (en) | 2022-02-01 |
| US9029136B2 (en) | 2015-05-12 |
| AU2013293116B2 (en) | 2019-06-06 |
| CA2879677C (en) | 2022-06-21 |
| AU2019226246A1 (en) | 2019-09-26 |
| AU2019203433A1 (en) | 2019-07-18 |
| WO2014018596A2 (en) | 2014-01-30 |
| WO2014018596A3 (en) | 2014-04-24 |
| JP2015529453A (ja) | 2015-10-08 |
| JP2020127403A (ja) | 2020-08-27 |
| AU2019203433B2 (en) | 2021-11-04 |
| JP6944886B2 (ja) | 2021-10-06 |
| EP2877574A2 (en) | 2015-06-03 |
| US20140031541A1 (en) | 2014-01-30 |
| AU2013293116A8 (en) | 2016-03-31 |
| US10273516B2 (en) | 2019-04-30 |
| EP2877574A4 (en) | 2016-07-20 |
| EP2877574B1 (en) | 2019-05-15 |
| JP2018093883A (ja) | 2018-06-21 |
| US20170081689A1 (en) | 2017-03-23 |
| HUE044693T2 (hu) | 2019-11-28 |
| CA2879677A1 (en) | 2014-01-30 |
| JP6355632B2 (ja) | 2018-07-11 |
| US20200087691A1 (en) | 2020-03-19 |
| AU2019203433C1 (en) | 2022-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202003200B (en) | Compositions, methods, and systems for the synthesis and use of imaging agents | |
| HUE044693T2 (hu) | Fukozilezett oligoszaccharidok elõállitására alkalmazható alfa (1,2) fukoziltranszferázok | |
| EP3488847C0 (en) | SEMIFLUORINATED ALKANE COMPOSITIONS | |
| DK3263564T3 (da) | Aza-aryl-1h-pyrazol-1-yl-benzen-sulfonamider som ccr(9)- antagonister | |
| HRP20180838T1 (hr) | Formuliranje deksmedetomidina u obliku predsmjese | |
| BR112015002512A2 (pt) | limpador interdental | |
| BR112015006198A2 (pt) | conjunto de cadeira | |
| BR302012003594S1 (pt) | "configuração aplicada em fraco" | |
| DK2877019T3 (da) | Sikkerede herbisidiske sammensætninger til anvendelse i ris | |
| EP2893918A4 (en) | ORAL COMPOSITION | |
| EP2825443A4 (en) | ADJUSTABLE KAYAK SEAT | |
| DK2844309T3 (da) | Selektivt polymeriserbare sammensætninger | |
| SI3138916T1 (sl) | Imunogeni sestavek | |
| HRP20181663T1 (hr) | Priprema (s,s)-sekoizolaricirezinol diglukozida i (r,r)-sekoizolaricirezinol diglukozida | |
| IL251177A0 (en) | Parasitic preparations containing benzaimidazole history, methods and uses | |
| ES2651188T8 (es) | Composición líquida fotopolimerizable | |
| EP3009497A4 (en) | Cleanser composition | |
| PL2762131T3 (pl) | Zastosowanie wyciągów z Salvia Haenkei w kompozycjach przeciwsenescencyjnych | |
| DK3265429T3 (da) | Nanopartikler til anvendelse som hæftningscentre i superledere | |
| EP2995294A4 (en) | Bathing agent composition | |
| EP2941134A4 (en) | Liquid stevia compositions | |
| DK2851075T3 (da) | Præparat, der indeholder 6,7-umættet -7-carbamoylmorphinanderivat | |
| DK3030597T3 (da) | Kædetermineret polymersammensætning, anvendelse deraf og fremgangsmåde til fremstilling deraf | |
| EP2933273A4 (en) | POLYMERIZABLE COMPOSITION | |
| BR302012006330S1 (pt) | Configuração aplicada em toalheiro. |